An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer.

J Clin Med · 2022 · PMC9739901 · PMID 36498683

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

a nonsignificant trendp = 0.12not close (p > 0.1)

A nonsignificant trend toward increased OS was observed; median OS was 14.5 months vs. 12.5 months, respectively (HR = 0.85, p = 0.12); RR improved to 35% vs. 10% with the addition of panitumumab.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.